NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 3226-3250 out of 3512.

<< < 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 > >>

Public Release: 27-Nov-2013
Science Translational Medicine
Clinical trial shows tongue-controlled wheelchair outperforms popular wheelchair navigation system
Individuals with paralysis in a new clinical trial were able to use a tongue-controlled technology to access computers and execute commands for their wheelchairs at speeds that were significantly faster than those recorded in sip-and-puff wheelchairs, but with equal accuracy. The new study is the first to show that the wireless and wearable Tongue Drive System outperforms sip-and-puff in controlling wheelchairs. Sip-and-puff is the most popular assistive technology for controlling a wheelchair.
NIH/National Institute of Biomedical Imaging and Bioengineering, National Science Foundation

Contact: Brett Israel
brett.israel@comm.gatech.edu
404-385-1933
Georgia Institute of Technology

Public Release: 27-Nov-2013
Cell
Genetic mutation increases risk of Parkinson's disease from pesticides
A study uses patient-derived stem cells to show that a mutation in the alpha-synuclein gene causes increased vulnerability to pesticides, leading to Parkinson's disease.
National Institutes of Health

Contact: Susan Gammon, Ph.D.
sgammon@sanfordburnham.org
858-795-5012
Sanford-Burnham Medical Research Institute

Public Release: 27-Nov-2013
New England Journal of Medicine
Pitt unlocks trove of public health data to help fight deadly contagious diseases
In an unprecedented windfall for public access to health data, University of Pittsburgh Graduate School of Public Health researchers have digitized all weekly surveillance reports for reportable diseases in the US going back 125 years. The database, described in the New England Journal of Medicine, is free and public. Supported by the Bill & Melinda Gates Foundation and the National Institutes of Health, the project's goal is to aid in the eradication of devastating diseases.
National Institutes of Health, Bill & Melinda Gates Foundation

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 26-Nov-2013
PLOS ONE
Scientists design and test new approach for corneal stem cell treatments
Researchers in the Cedars-Sinai Regenerative Medicine Institute have designed and tested a novel, minute-long procedure to prepare human amniotic membrane for use as a scaffold for specialized stem cells that may be used to treat some corneal diseases. This membrane serves as a foundation that supports the growth of stem cells in order to graft them onto the cornea.
National Institutes of Health, Cedars-Sinai Regenerative Medicine Institute

Contact: Cara Martinez
cara.martinez@cshs.org
310-423-7798
Cedars-Sinai Medical Center

Public Release: 26-Nov-2013
Developmental Cell
UCLA research may help scientists understand what causes pregnancy complications
Dr. Hanna Mikkola and researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified a specific type of cell and a related cell communication pathway that are key to the successful growth of a healthy placenta. The findings could greatly bolster our knowledge about the potential causes of complications during pregnancy.
National Institutes of Health, UCLA/Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles

Public Release: 26-Nov-2013
Ophthalmology
National study finds donor age not a factor in most corneal transplants
Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, and corneas from donors over 71 perform slightly less well but still remain healthy for most transplant recipients, according to a study funded by the National Eye Institute and led by the UC Davis Health System Eye Center and the University of Cincinnati Eye Institute.
NIH/National Eye Institute, Eye Bank Association of America, Bausch & Lomb, Tissue Banks International, Vision Share

Contact: Carole Gan
carole.gan@ucdmc.ucdavis.edu
916-734-9047
University of California - Davis Health System

Public Release: 26-Nov-2013
Neurology Clinical Practice
Kessler stroke researchers explore five new avenues for rehabilitation research
Because the concept of permanent neurological injury has given way to recognition of the brain's potential for long-term regeneration ad reorganization, rehabilitations strategies are undergoing radical changes. The potential for five new translational interventions was examined in an article published ahead of print on Nov. 13 by Neurology Clinical Practice. The five treatments are based on behavioral or non-invasive physiological stimulation.
National Institutes of Health, Kessler Foundation

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation

Public Release: 26-Nov-2013
Genes & Development
Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease
A team of researchers at Cold Spring Harbor Laboratory has identified a leukemia-specific stretch of DNA called an enhancer element that enables cancerous blood cells to proliferate in acute myeloid leukemia, a devastating cancer that is incurable in 70 percent of patients. Just as important, the findings offer a mechanistic insight into how a new class of promising drugs -- one version of which is already in human clinical trials -- appears to halt the growth of cancer cells so effectively.
National Institutes of Health

Contact: Jaclyn Jansen
jjansen@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory

Public Release: 26-Nov-2013
Journal of Neuroscience
Drug reduces brain changes, motor deficits associated with Huntington's disease
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing Nov. 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins -- the molecules that support the survival and function of nerve cells -- may slow the progression of Huntington's disease and other neurodegenerative disorders.
Taube Philanthropies, Koret Foundation, Jean Perkins Foundation, National Institutes of Health

Contact: Kathleen Snodgrass
ksnodgrass@sfn.org
202-962-4000
Society for Neuroscience

Public Release: 26-Nov-2013
Journal of the Association of Nurses in AIDS Care
Women living with HIV share their stories through photography
A University of Missouri researcher found that participating in photovoice, a process by which individuals document their lives by taking pictures, empowered women living with HIV to realize their strengths in the midst of their struggles.
National Institutes of Health

Contact: Jesslyn Chew
ChewJ@missouri.edu
573-882-8353
University of Missouri-Columbia

Public Release: 26-Nov-2013
Wayne State part of team for license on new ways to manage cancer with green tea extracts
Wayne State University, along with McGill University and the Hong Kong Polytechnic University, have executed an exclusive worldwide license with Viteava Pharmaceutical Inc. for an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, (-)epigallocatechin-3-gallate.
NIH/National Cancer Institute

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research

Public Release: 26-Nov-2013
RSNA and Regenstrief Institute launch effort to unify radiology procedure naming
Under a contract awarded by the National Institute of Biomedical Imaging and Bioengineering, the developers of two advanced medical terminologies have begun work to harmonize and unify terms for radiology procedures. Creating standardized radiology procedure names will improve the quality, consistency and interoperability of radiology test results in electronic medical record systems and health information exchange.
NIH/National Institute of Biomedical Imaging and Bioengineering

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University

Public Release: 26-Nov-2013
Cell Stem Cell
Researchers at Penn uncover mechanism behind blood stem cells' longevity
Researchers have long wondered what allows blood stem cells to persist for decades, when their progeny last for days, weeks or months before they need to be replaced. Now, a study from the University of Pennsylvania has uncovered one of the mechanisms that allow these stem cells to keep dividing in perpetuity.
National Institutes of Health, Human Frontier Science Program, American Heart Association

Contact: Evan Lerner
elerner@upenn.edu
215-573-6604
University of Pennsylvania

Public Release: 26-Nov-2013
Breast Cancer Research
High-fat diet during puberty speeds up breast cancer development
New findings show that eating a high-fat diet beginning at puberty speeds up the development of breast cancer and may actually increase the risk of cancer similar to a type often found in younger adult women.
NIH/National Institute of Environmental Health, NIH/National Cancer Institute

Contact: Sarina Gleason
sarina.gleason@cabs.msu.edu
517-355-9742
Michigan State University

Public Release: 26-Nov-2013
JAMA
Screening new inmates for HIV may not reveal many new undetected cases, study shows
More than 22,000 inmates entering North Carolina prisons in 2008 and 2009 were tested for HIV, but only 20 previously undiagnosed cases of HIV were found in this population.
NIH/National Institute on Drug Abuse

Contact: Lisa Chensvold
lisa_chensvold@med.unc.edu
919-843-5719
University of North Carolina Health Care

Public Release: 25-Nov-2013
Journal of Adolescent Health
Electronic cigarettes: New route to smoking addiction for adolescents
E-cigarettes have been widely promoted as a way for people to quit smoking conventional cigarettes. Now, in the first study of its kind, UC San Francisco researchers are reporting that, at the point in time they studied, youth using e-cigarettes were more likely to be trying to quit, but also were less likely to have stopped smoking and were smoking more, not less.
NIH/National Cancer Institute, University of California, Tobacco Related Diseases Research Program, Hellmann Family Fund

Contact: Elizabeth Fernandez
elizabeth.fernandez@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 25-Nov-2013
Einstein-Ferkauf researchers secure $2.5 million NIH grant to study diabetes self-management and behavioral interventions
Researchers at Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology, both affiliated with Yeshiva University, and the New York City Department of Health and Mental Hygiene have been awarded a $2.5 million grant from the National Institutes of Health to study a telephone-based approach to improving diabetes self-management and treatment outcomes in primary care.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine

Public Release: 25-Nov-2013
Proceedings of the National Academy of Sciences
Bad proteins branch out
Rice University theorists find that misfolded proteins form branched structures, which may have implications for Alzheimer's and other aggregation diseases.
National Institutes of Health, National Science Foundation

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University

Public Release: 25-Nov-2013
Icahn School of Medicine at Mount Sinai awarded $2.7 million from NIH to investigate novel therapy for eczema
The National Institutes of Health has awarded a research team at the Icahn School of Medicine at Mount Sinai $2.7 million to study systemic treatments for patients with moderate to severe atopic dermatitis, also known as eczema.
National Institutes of Health

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 25-Nov-2013
American Journal of Physiology
Childhood exercise may stave off some bad effects of maternal obesity
Rats whose mothers were fed a high-fat diet during pregnancy and nursing were able to stave off some of the detrimental health effects of obesity by exercising during their adolescence, new Johns Hopkins research shows.
NIH/National Institute of Child Health and Human Development

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

Public Release: 25-Nov-2013
Nature Biotechnology
First large-scale PheWAS study using EMRs provides systematic method to discover new disease association
Vanderbilt University Medical Center researchers and co-authors from four other US institutions from the Electronic Medical Records and Genomics Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study, released today in Nature Biotechnology.
National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 25-Nov-2013
Proceedings of the National Academy of Sciences
UCI, Northwestern researchers create compounds that boost antibiotics' effectiveness
Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.
National Institutes of Health

Contact: Andrea Burgess
andrea.burgess@uci.edu
949-824-6282
University of California - Irvine

Public Release: 25-Nov-2013
PLOS ONE
2-way traffic enables proteins to get where needed, avoid disease
It turns out that your messenger RNA may catch more than one ride to get where it's going.
National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 25-Nov-2013
Oncogene
UNC scientists find potential cause for deadly breast cancer relapse
Adriana S. Beltran, Ph.D., a research assistant professor in the UNC School of Medicine, found that the protein Engrailed 1 is overexpressed in basal-like carcinomas, and she designed a chain of amino acids to shut down the protein and kill basal-like tumors in the lab.
National Institutes of Health, US Department of Defense

Contact: Mark Derewicz
mark.derewicz@unch.unc.edu
919-923-0959
University of North Carolina Health Care

Public Release: 25-Nov-2013
American Journal of Medicine
Obesity associated with higher risk of hearing loss in women
New research shows that a higher body mass index and larger waist circumference are each associated with higher risk of hearing loss, while a higher level of physical activity is associated with lower risk of hearing loss in women.
National Institutes of Health, Vanderbilt University School of Medicine

Contact: Lori J Schroth
ljschroth@partners.org
617-525-6374
Brigham and Women's Hospital

Showing releases 3226-3250 out of 3512.

<< < 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.